Drug Channels Archive for November, 2021

Click a link below to view the mailing archive as if it had been sent to you.

2021-11-23 07:44Drug Channels News Roundup, November 2021: Specialty Pharmacy Checkup, Insulin Profits, Gross-to-Net Bubble Update, CVS & 340B, and Amazon Redux
2021-11-19 07:37Drug Channels - Pathway or Perish: The Two-Pronged Hurdle to Ensuring Access in Oncology
2021-11-18 07:46Drug Channels - Small Pharmacies Continue to Run Away from Medicare Part D's Preferred Networks
2021-11-16 07:46Drug Channels - CVS, Walgreens, Walmart, and Supermarkets Keep Position in 2022 Part D Preferred Networks—With a Little Help from 340B
2021-11-15 07:46Drug Channels Outlook 2022 (NEW Live Video Webinar)
2021-11-09 07:46Drug Channels - Why PBMs and Payers Are Embracing Insulin Biosimilars with Higher Prices—And What That Means for Humira
2021-11-08 07:36Drug Channels - Informa Connect''s Trade & Channel Strategies
2021-11-05 07:36Drug Channels - Risk-Based Cancer Care: A Specialty Pharmacy's Role
2021-11-02 07:46Drug Channels - Consolidation and Preferred Pharmacy Networks in 2022's Medicare Part D Plans: Cigna, CVS Health, Humana, UnitedHealthcare, WellCare, and More


<< Archive IndexSubscribe >>